Delivery Order SPE2DB20D2104-SPE2DB23FT00J
Award Date
4/10/23
Potential Completion Date
4/11/23
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Ramipril 2.5 mg capsules, a cardiovascular medication, to the Defense Logistics Agency (DLA). The contract, valued at $1,894.88, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 30, 2024, with a completion date of January 31, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of 4,564,320 units of Ramipril 10 mg capsules to the Defense Logistics Agency (DLA). The contract, valued at $2,389.32, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award, valued at $1,279.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order for the supply of 500 capsules of the pharmaceutical drug Ramipril 10 mg. The contract has a ceiling value of $1,279.26 and is set to be completed by September 17, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide essential medical...
This federal contract award, valued at $12,976.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Ramipril 10 mg capsules, a medication used to treat high blood pressure and heart failure. The contract has an ultimate completion date of March 8, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,616.20 firm fixed-price delivery order covers the supply of RAMIPRIL 10 MG CAPSULE 100S, a cardiovascular medication. The contract has an ultimate completion date of February 13, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,494.33 firm fixed-price delivery order is for the supply of RAMIPRIL 2.5 MG CAPSULE 500S, a cardiovascular medication, with a period of performance through April 17, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,129.43 firm fixed-price delivery order is for the supply of 500 capsules of 10 mg Ramipril, a medication used to treat high blood pressure and heart failure. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award, with ID SPE2DB20D2104|SPE2DB24FS77A, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,899.68 firm-fixed-price delivery order is for the supply of 4,563,789,849 units of the 10 mg Ramipril capsule medication. The award has an ultimate completion date of February 28, 2024 and was made on February 27, 2024. This contract is not designated as a set-aside....
This federal contract award is for the delivery of Ramipril 2.5 mg capsules to the Defense Logistics Agency (DLA). The $1,131.00 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on September 19, 2022. The contract has a completion date of September 20, 2022 and was not set aside for any specific business category. Amerisourcebergen is a major pharmaceutical distributor that holds two significant Indefinite Delivery Contracts (IDCs) with...
This federal contract award, with an ID of SPE2DB22D2206|SPE2DB24FEY62, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,633.81, is for the delivery of 4563248843 Ramipril 10 mg capsules. This appears to be a Firm Fixed Price Delivery Order contract with a completion date of January 8, 2024. The contract is not designated as a set-aside award. Amerisourcebergen holds a...